| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Options Exercise | $283,200 | +10,000 | +157% | $28.32* | 16,382 | 26 Oct 2021 | Direct | F1 |
| transaction | MEDP | Common Stock | Sale | $2,113,600 | -10,000 | -61% | $211.36 | 6,382 | 26 Oct 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -10,000 | -59% | $0.000000 | 7,000 | 26 Oct 2021 | Common Stock | 10,000 | $28.32 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $204.53 to $214.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | Each option vested on March 15, 2021. |